As shown in our aforementioned study, in subpopulations of patients with SLE, T cells exhibit enhanced IL-12/tyrosine kinase (TYK) 2/STAT4 signaling, and Tfh/Th1-like cells are activated [45]. Here, STAT4 is linked to systemic lupus erythematosus.